ARAY stock news · Accuray Incorporated
Get alerts for ARAY
Follow Accuray Incorporated (ARAY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ARAYAccuray Inc. announced that director Mika Nishimura is leaving and won’t run for re-election in 2026.
NeutralAccuray director Mika Nishimura plans to leave the board after the November 2026 meeting and cited no company dispute. This planned change does not signal a shift in the company's outlook.
Here are 12 health care stocks that changed in value after the market closed on Monday.
NeutralAccuray shares fell in after-hours trading. The report gives no business reason for the move, so it does not change the company's outlook.
On Friday evening, 12 health care stocks saw big changes in their prices.
NeutralAccuray's shares rose about 6% after hours, but the report gives no company news to change its business outlook.
12 health care stocks changed a lot in prices after the market closed on Tuesday.
NeutralThe article reports Accuray shares fell 12%, but gives no company news behind the move. It does not change the business outlook.
12 health care stocks are changing a lot before the market opens on Tuesday.
NeutralAccuray was listed among pre-market decliners. The article gives no company news explaining the move, so it does not change the view of its business.
Here are 12 health care stocks that changed a lot during Monday's trading.
NeutralAccuray shares rose about 58%, but the article gives no company news explaining the move. It does not change Accuray's business outlook.
12 health care stocks are changing a lot before the market opens on Monday.
NeutralThe report says Accuray shares rose 50.16% to $0.32 before trading. It gives no company news explaining the move, so the story does not change Accuray's outlook.
Accuray's stock is going up today because of a new partnership with Samsung NeuroLogica.
NeutralAccuray is exploring CyberKnife imaging with Samsung NeuroLogica, but no product has been announced. Mixed recent results leave no clear change in its outlook.
Complete Transcript of Accuray's Q4 2026 Earnings Conference Call.
Bad for ARAYAccuray's fourth-quarter earnings report indicates a significant decline in revenue, primarily due to lower product sales, particularly in China. The company is taking steps to improve its financial position through a strategic transaction involving debt conversion and cash investment.